טוען...

Ebselen Is a Potential Anti-Osteoporosis Agent by Suppressing Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Osteoclast Differentiation In vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In vivo

Ebselen is a non-toxic seleno-organic drug with anti-inflammatory and antioxidant properties that is currently being examined in clinical trials to prevent and treat various diseases, including atherosclerosis, stroke, and cancer. However, no reports are available for verifying the pharmacological e...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Int J Biol Sci
Main Authors: Baek, Jong Min, Kim, Ju-Young, Yoon, Kwon-Ha, Oh, Jaemin, Lee, Myeung Su
פורמט: Artigo
שפה:Inglês
יצא לאור: Ivyspring International Publisher 2016
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4807414/
https://ncbi.nlm.nih.gov/pubmed/27019631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.13815
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!